BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37920449)

  • 21. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
    Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
    Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A composite risk model predicts disease progression in early stages of COVID-19: A propensity score-matched cohort study.
    Xu J; Gao Y; Hu S; Li S; Wang W; Wu Y; Su Z; Zhou X; Cheng X; Zheng Q
    Ann Clin Biochem; 2021 Sep; 58(5):434-444. PubMed ID: 33827266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The implications of preliminary screening and diagnosis: Clinical characteristics of 33 mild patients with SARS-CoV-2 infection in Hunan, China.
    Yin S; Peng Y; Ren Y; Hu M; Tang L; Xiang Z; Li X; Wang M; Wang W
    J Clin Virol; 2020 Jul; 128():104397. PubMed ID: 32388472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum biomarker panel for disease severity and prognosis in patients with COVID-19.
    Li J; Tang M; Liu D; Xie Z; Wang F; Yang Y
    J Clin Lab Anal; 2023 Jan; 37(2):e24831. PubMed ID: 36604799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination of serum lactate dehydrogenase and sex is predictive of severe disease in patients with COVID-19.
    Hu J; Zhou J; Dong F; Tan J; Wang S; Li Z; Zhang X; Zhang H; Ming J; Huang T
    Medicine (Baltimore); 2020 Oct; 99(42):e22774. PubMed ID: 33080747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased lactate dehydrogenase reflects the progression of COVID-19 pneumonia on chest computed tomography and predicts subsequent severe disease.
    Kojima K; Yoon H; Okishio K; Tsuyuguchi K
    Sci Rep; 2023 Jan; 13(1):1012. PubMed ID: 36653462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Laboratory analysis of symptomatic and asymptomatic pregnant patients with SARS-CoV-2 infection.
    Fisher SA; Goldstein JA; Mithal LB; Isaia AL; Shanes ED; Otero S; Miller ES
    Am J Obstet Gynecol MFM; 2021 Nov; 3(6):100458. PubMed ID: 34403821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis.
    Ghahramani S; Tabrizi R; Lankarani KB; Kashani SMA; Rezaei S; Zeidi N; Akbari M; Heydari ST; Akbari H; Nowrouzi-Sohrabi P; Ahmadizar F
    Eur J Med Res; 2020 Aug; 25(1):30. PubMed ID: 32746929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lactate-dehydrogenase associated with mortality in hospitalized patients with COVID-19 in Mexico: a multi-centre retrospective cohort study.
    Vidal-Cevallos P; Higuera-De-La-Tijera F; Chávez-Tapia NC; Sanchez-Giron F; Cerda-Reyes E; Rosales-Salyano VH; Servin-Caamaño A; Vázquez-Medina MU; Méndez-Sánchez N
    Ann Hepatol; 2021; 24():100338. PubMed ID: 33647501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytokine storm in severe COVID-19 pneumonia.
    Gürsoy B; Sürmeli CD; Alkan M; Satıcı C; Altunok ES; Kamat S; Demirok B; Demirkol MA; Börü A
    J Med Virol; 2021 Sep; 93(9):5474-5480. PubMed ID: 33963559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. All-cause mortality in moderate and severe COVID-19 patients with myocardial injury receiving versus not receiving azvudine: a propensity score-matched analysis.
    Chen R; Guo Y; Deng S; Wang J; Gao M; Han H; Wang L; Jiang H; Huang K
    Cardiol Plus; 2023; 8(2):103-110. PubMed ID: 37539021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated Lactate Dehydrogenase (LDH) level as an independent risk factor for the severity and mortality of COVID-19.
    Li C; Ye J; Chen Q; Hu W; Wang L; Fan Y; Lu Z; Chen J; Chen Z; Chen S; Tong J; Xiao W; Mei J; Lu H
    Aging (Albany NY); 2020 Aug; 12(15):15670-15681. PubMed ID: 32805722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of risk factors for in-hospital death of COVID - 19 pneumonia -- lessions from the early outbreak.
    Wang Z; Wang Z
    BMC Infect Dis; 2021 Jan; 21(1):113. PubMed ID: 33494706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Azvudine for the Treatment of COVID-19 in Pre-Existing Cardiovascular Diseases: A Single-Center, Real-World Experience.
    Wu L; He ZH; Huang L; Guo X; Li XY; Zhang HD; Chen MH
    Adv Sci (Weinh); 2024 Mar; ():e2306050. PubMed ID: 38544344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lactate dehydrogenase and susceptibility to deterioration of mild COVID-19 patients: a multicenter nested case-control study.
    Shi J; Li Y; Zhou X; Zhang Q; Ye X; Wu Z; Jiang X; Yu H; Shao L; Ai JW; Zhang H; Xu B; Sun F; Zhang W
    BMC Med; 2020 Jun; 18(1):168. PubMed ID: 32493370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laboratory biomarker predictors for disease progression and outcome among Egyptian COVID-19 patients.
    Fathalla LA; Kamal LM; Salaheldin O; Khalil MA; Kamel MM; Fahim HH; Abdel-Moneim YA; Abdulhakim JA; Abdel-Moneim AS; El-Meligui YM
    Int J Immunopathol Pharmacol; 2022; 36():3946320221096207. PubMed ID: 35622504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Covid-19: contribution of clinical characteristics and laboratory features for early detection of patients with high risk of severe evolution.
    Sepulchre E; Pittie G; Stojkovic V; Haesbroek G; Crama Y; Schyns M; Paridaens H; de Marchin J; Degesves S; Biemar C; Boccar S; Senterre JM; Minon JM
    Acta Clin Belg; 2022 Apr; 77(2):261-267. PubMed ID: 32935644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inflammatory markers are poorly predictive of clinical outcomes among hospitalized patients with COVID-19.
    Barrett B; Pamphile S; Yang F; Naeem F; Kim J; Annam J; Borczuk R; Yellin S; Bass C; Fowler S; Mosheyev M; Mayer YJ; Friedman BW
    Am J Emerg Med; 2021 Aug; 46():595-598. PubMed ID: 33280969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lactate dehydrogenase and PaO2/FiO2 ratio at admission helps to predict CT score in patients with COVID-19: An observational study.
    Russo A; Pisaturo M; De Luca I; Schettino F; Maggi P; Numis FG; Gentile I; Sangiovanni V; Rossomando AM; Gentile V; Calabria G; Rescigno C; Megna AS; Masullo A; Manzillo E; Russo G; Parrella R; Dell'Aquila G; Gambardella M; Ponticiello A; Reginelli A; Coppola N;
    J Infect Public Health; 2023 Jan; 16(1):136-142. PubMed ID: 36521329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High triglyceride to HDL-cholesterol ratio as a biochemical marker of severe outcomes in COVID-19 patients.
    Alcántara-Alonso E; Molinar-Ramos F; González-López JA; Alcántara-Alonso V; Muñoz-Pérez MA; Lozano-Nuevo JJ; Benítez-Maldonado DR; Mendoza-Portillo E
    Clin Nutr ESPEN; 2021 Aug; 44():437-444. PubMed ID: 34330502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.